Episode 14: America's Healthcare Scam (w/ Andrew Langer)

Healthcare's bleeding Americans dry, and we're diving straight into the guts of why. Andrew Langer, President of the Institute for Liberty, joins Brady Knolwton to rip apart the myth that this is just an "insurance problem." Nah. This is basic economics: massive demand, vanishing supply. We're talking doctor shortages, nurse shortages, and a regulatory machine that's choking innovation to death.Americans are bankrolling drug development for the entire world while foreign countries freeload with price controls. Meanwhile, Pharmacy Benefit Managers are playing games with your wallet, and nobody's talking about the real fix: flooding the market with more healthcare professionals.Andrew breaks down the trade wars we're not fighting, the regulatory state that needs gutting, and why increasing supply beats every other "solution" politicians are peddling.This is kitchen table reality hitting every American family. Ready to dig into what it'll actually take to fix this broken system?About Andrew Langer:President of the Institute for Liberty. Veteran voice on regulatory policy, trade, and healthcare economics. Seen on major networks, heard on radio, testified before Congress. Andrew cuts through the noise and calls it straight.#Healthcare #DrugPrices #Economics #USHealthcare #Policy #Innovation #DoctorShortageTimestamps00:00 - Introduction: Healthcare as a Resource Economics Problem00:26 - The Growing Shortage of Doctors in the U.S.01:06 - Why Are US Drug Prices So High?01:37 - Are Americans Subsidizing Drug Costs for the Rest of the World?02:07 - The Role of US Regulations in High Drug Prices03:17 - The Dangers of Price Controls (Foreign and Domestic)03:37 - What is "Most Favored Nation" Status for Drug Pricing?04:03 - The Best Way to Bring Prescription Drug Prices Down05:03 - Abusing the Patent Exclusivity Period05:45 - Putting Pressure on Other Nations to Pay Their Fair Share06:56 - Unfair Trade Practices: How to Negotiate with Other Countries08:26 - Using Tariffs as a Tool in Drug Price Negotiations09:38 - Bureaucracy at Home: The Regulatory Burden on Pharma10:36 - The Critical Difference Between Health Insurance and Health Care11:34 - How to Increase Supply and Still Incentivize Innovation12:02 - It's Not Just Drugs: We Need More Doctors and Nurses12:47 - The Problem with Pharmacy Benefit Managers (PBMs)14:10 - Why Don't We Have More Doctors?15:10 - The Vicious Cycle: How Policy Impacts the Doctor Supply17:11 - The Need for Reciprocal Residency Programs with Other Nations18:39 - Are Trade Associations Just Another Form of Bureaucracy?19:45 - Real-World Solutions to Cut the Bureaucratic BurdenFIND BRADY ON SOCIALX/Twitter: https://x.com/vivamusverumTikTok: https://www.tiktok.com/@bradys_most_interestingInstagram: https://www.instagram.com/bradysmostinteresting/FIND ANDREW LANGER ON SOCIALX/Twitter: https://x.com/Andrew_LangerLinkedIn: https://www.linkedin.com/in/andrew-langer-2265b81